129 related articles for article (PubMed ID: 21797121)
1. Immunological evaluation of vaginal secretion in patients with high-grade cervical intraepithelial neoplasia treated with intralesional interferon alpha-2b.
Mardegan MC; Ramos MC; Adad SJ; Michelin MA; Shimba D; Murta EF
Eur J Gynaecol Oncol; 2011; 32(3):297-302. PubMed ID: 21797121
[TBL] [Abstract][Full Text] [Related]
2. Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2b.
Misson DR; Abdalla DR; Borges AM; Shimba DS; Adad SJ; Michelin MA; Murta EF
Tumori; 2011; 97(5):578-84. PubMed ID: 22158487
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytokines in cervical stroma in patients with high-grade cervical intraepithelial neoplasia after treatment with intralesional interferon alpha-2b.
Ramos MC; Mardegan MC; Peghini BC; Adad SJ; Michelin MA; Murta EF
Eur J Gynaecol Oncol; 2010; 31(5):522-9. PubMed ID: 21061793
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of immune system cell infiltrate in the cervical stroma of patients with grade III cervical intraepithelial neoplasia after treatment with intralesional alpha-2B interferon.
Machado FA; Abdalla DR; Montes L; Etchebehere RM; Michelin MA; Murta EF
Eur J Gynaecol Oncol; 2014; 35(1):20-5. PubMed ID: 24654456
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human interferon gamma in the treatment of cervical intraepithelial neoplasia (CIN) associated with human papillomavirus (HPV) infection.
Sikorski M; Zrubek H
Eur J Gynaecol Oncol; 2003; 24(2):147-50. PubMed ID: 12701965
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study.
Toma S; Ragni N; Raffo P; Boselli F; Gustavino C; Rugiati S; Formelli F; Palumbo R; Rosso R; De Cecco L
Anticancer Res; 1996; 16(2):931-6. PubMed ID: 8687154
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
[TBL] [Abstract][Full Text] [Related]
8. Intralesional beta-interferon treatment of cervical intraepithelial neoplasia associated with human papillomavirus infection.
Penna C; Fallani MG; Gordigiani R; Sonni L; Taddei GL; Marchionni M
Tumori; 1994 Apr; 80(2):146-50. PubMed ID: 8016908
[TBL] [Abstract][Full Text] [Related]
9. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
Belinson JL; Hu S; Niyazi M; Pretorius RG; Wang H; Wen C; Smith JS; Li J; Taddeo FJ; Burchette RJ; Qiao YL
Int J Cancer; 2010 Sep; 127(5):1151-7. PubMed ID: 20039323
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients treated with recombinant human interferon gamma for cervical intraepithelial neoplasia.
Sikorski M; Zrubek H
Int J Gynaecol Obstet; 2003 Aug; 82(2):179-85. PubMed ID: 12873779
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion.
Santos AL; Derchain SF; Martins MR; Sarian LO; Martinez EZ; Syrjänen KJ
Sao Paulo Med J; 2003 Nov; 121(6):238-43. PubMed ID: 14989139
[TBL] [Abstract][Full Text] [Related]
13. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha 2b treatment of cervical intraepithelial neoplasia grade 2: modulation of natural killer cell.
Garzetti GG; Ciavattini A; Romanini C; Goteri G; Tranquilli AL; Muzzioli M; Fabris N
Gynecol Obstet Invest; 1994; 37(3):204-9. PubMed ID: 8005554
[TBL] [Abstract][Full Text] [Related]
15. Intralesional recombinant alpha 2B interferon in the treatment of human papillomavirus-associated cervical intraepithelial neoplasia.
Stellato G
Sex Transm Dis; 1992; 19(3):124-6. PubMed ID: 1326126
[TBL] [Abstract][Full Text] [Related]
16. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).
Acladious NN; Sutton C; Mandal D; Hopkins R; Zaklama M; Kitchener H
Int J Cancer; 2002 Mar; 98(3):435-9. PubMed ID: 11920596
[TBL] [Abstract][Full Text] [Related]
17. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
18. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.
Zielinski GD; Rozendaal L; Voorhorst FJ; Berkhof J; Snijders PJ; Risse EJ; Runsink AP; de Schipper FA; Meijer CJ
Gynecol Oncol; 2003 Oct; 91(1):67-73. PubMed ID: 14529664
[TBL] [Abstract][Full Text] [Related]
19. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
